Intelligence / Healthtech / PMA Approvals / Rejoni, INC.
Approvalsnew device approved (PMA)28 Sept 2026
Rejoni, INC.
28 Sept 2026: New device approved (PMA) · Juveena Hydrogel System. Recorded in the openFDA device PMA data.
- Decided
- 28 Sept 2026
- Device
- Juveena Hydrogel System
- Specialty
- Obstetrics/Gynecology
- Type
- Original approval
- Reference
- P250051
- Location
- Bedford, MA
What this signal means
A PMA approval is a high-risk device launch: reimbursement, distribution, clinical training and sales hires follow.
- Cardiovascular leads with 53 of 120, then Pathology (15).
- 35 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at Rejoni, INC.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
Source: openFDA device PMA data, data to 18 Nov 2026. Class III devices approved by FDA: original approvals and supplements that change the device (180-day, panel-track and special tracks). 30-day manufacturing notices are left out. AOS shows what the public record says; it does not verify or endorse the company.